Here’s what you should know:
1. BidaskClub assigned Surgery Partners a sell rating in its latest research note.
2. Stifel Nicolaus assigned the company a hold rating, but dropped its price objective from $19 a share to $18 a share.
3. On average analysts project a price target of $21.40 for Surgery Partners.
4. Surgery Partners closed Jan. 24 at $21.38.
More articles on transactions/valuations:
Concord Orthopaedics’ ASC plans up in the air due to rezoning concerns: 4 takeaways
Compass Surgical Partners opens multispecialty ASC & more — 5 ASC company key notes
Compass Surgical Partners opens freestanding Florida ASC: 4 key points
